1. Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
   Kira V. Blankenbach et al, 2016, Front. Pharmacol. CrossRef
2. Regulation of adipogenesis by ceramide 1-phosphate
   Marta Ordoñez et al, 2018, Experimental Cell Research CrossRef
3. Obesity and dyslipidemia
   Jelena Vekic et al, 2018, Metabolism CrossRef
4. Ceramide and sphingosine 1-phosphate in adipose dysfunction
   Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
5. Ceramide and sphingosine 1-phosphate in adipose dysfunction
   Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
6. The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells – new opportunities in regenerative medicine
   Krzysztof Marycz et al, 2015 CrossRef
7. A review on possible therapeutic targets to contain obesity: The role of phytochemicals
   Meriga Balaji et al, 2016, Obesity Research & Clinical Practice CrossRef
8. Implication of phosphatidylethanolamine N-methyltransferase in adipocyte differentiation
   Natalia Presa et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
9. Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes
   Xiyuan Wu et al, 2020, IJMS CrossRef
10. Novel insights into the pathological mechanisms of metabolic related dyslipidemia
    Xin Su et al, 2021, Mol Biol Rep CrossRef
11. Adipose Tissue Immunometabolism and Apoptotic Cell Clearance
    Tamás Röszer, 2021, Cells CrossRef
12. S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
    Sagarika Chakrabarty et al, 2022, Adipocyte CrossRef